HALEIGH BOE: Open Payments
NPI 1902388358 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 54 payments from 25 companies in 2025. Trend: 2023 $4,507 · 2024 $5,212 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $297 |
| Lundbeck LLC | 3 | $89 |
| Neurelis, Inc. | 3 | $81 |
| InSightec,Inc | 3 | $79 |
| Lilly USA, LLC | 4 | $67 |
| Alexion Pharmaceuticals, Inc. | 2 | $66 |
| ABBVIE INC. | 3 | $53 |
| TG Therapeutics, Inc. | 2 | $53 |
| Biogen, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
Products named: Zilbrysq, VYEPTI, VALTOCO, Exablate, ULTOMIRIS, Fintepla, BRIUMVI, Briviact.
Industry payments across CA — which companies pay providers there.
